You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

BP-CML

Showing 1 - 25 of 1,624
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Philadelphia Chromosome, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Suzhou (Azacitidine, Venetoclax,

Recruiting
  • Philadelphia Chromosome
  • +4 more
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Jun 23, 2022

Recurrent Adult Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome Trial in Houston (BP1001, BP1001

Completed
  • Recurrent Adult Acute Myeloid Leukemia
  • +3 more
  • BP1001
  • BP1001 in combination with LDAC
  • Houston, Texas
    M. D. Anderson Cancer Center
May 26, 2020

Chronic Myelogenous Leukemia, Ph1-Positive, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Houston (BP1001 (varying

Withdrawn
  • Chronic Myelogenous Leukemia, Ph1-Positive
  • +2 more
  • BP1001 (varying dose)
  • +2 more
  • Houston, Texas
    The University of Texas M.D. Anderson Cancer Center
May 26, 2020

3rd Line Therapy or More to Treat Adult CML- CP in Real World

Not yet recruiting
  • Chronic Myeloid Leukemia
  • Asciminib
  • (no location specified)
Oct 16, 2023

CML Any Phase of the Disease Treated With Ponatinib (Iclusig®)

Active, not recruiting
  • Chronic Myeloid Leukemia
    • Saint-Pierre, Reunion, France
    • +39 more
    Dec 13, 2021

    Healthy (For Part A), Chronic Myeloid Leukemia (for Part B and C) Trial in Worldwide (Vodobatinib (K0706) capsules)

    Recruiting
    • Healthy (For Part A)
    • Chronic Myeloid Leukemia (for Part B and C)
    • Vodobatinib (K0706) capsules
    • Downey, California
    • +69 more
    Dec 7, 2022

    Leukemia Trial in Worldwide (Dasatinib)

    Active, not recruiting
    Has Results
    • Leukemia
    • Birmingham, Alabama
    • +173 more
    Dec 1, 2022

    CALLS: CML and Ph+ALL Low Level Mutation Prevalence Survey

    Completed
    • Chronic Phase Chronic Myelogenous Leukemia
    • +3 more
      • Limerick, Dooradoyle, Ireland
      • +32 more
      Aug 13, 2021

      CML, Chronic Phase Trial in Harbin (Flumatinib, Imatinib)

      Not yet recruiting
      • CML, Chronic Phase
      • Harbin, Heilongjiang, China
        Institute of Hematology and Oncology, Harbin The First Hospital
      May 5, 2022

      Chronic Phase Chronic Myeloid Leukemia Trial in Bruxelles (Ponatinib 30 mg QD, Ponatinib 15 mg QD, Nilotinib 400 mg BID)

      Terminated
      Has Results
      • Chronic Phase Chronic Myeloid Leukemia
      • Ponatinib 30 mg QD
      • +2 more
      • Bruxelles, Belgium
        Cliniques Universitaire Saint-Luc (Site 058)
      Oct 28, 2021

      Chronic Myeloid Leukemia, Ph+ Acute Lymphoblastic Leukemia Trial in Worldwide (Ponatinib)

      Completed
      Has Results
      • Chronic Myeloid Leukemia
      • Ph+ Acute Lymphoblastic Leukemia
      • St Leonards, New South Wales, Australia
      • +41 more
      Jan 18, 2021

      Myeloid Leukemia, Chronic, Chronic Phase Trial in Worldwide (Ponatinib)

      Active, not recruiting
      Has Results
      • Myeloid Leukemia, Chronic, Chronic Phase
      • Atlanta, Georgia
      • +85 more
      Jan 4, 2022

      Vascular Occlusive Events Associated With ICLUSIG®

      Terminated
      • Myeloid Leukemia, Chronic-Phase, Accelerated-Phase, Blast-Phase, Ph+ALL
        • Hackensack, New Jersey
        • +1 more
        Oct 30, 2020

        Chronic Myeloid Leukemia Trial in Worldwide

        Recruiting
        • Chronic Myeloid Leukemia
          • Montréal, Quebec, Canada
          • +25 more
          Jul 25, 2022

          Acute Myeloid Leukemia, Accelerated Phase Chronic Myeloid Leukemia, Blast Phase Chronic Myeloid Leukemia Trial in Worldwide

          Recruiting
          • Acute Myeloid Leukemia
          • +8 more
          • Ghent, Belgium
          • +28 more
          Nov 11, 2022

          Chronic Myelogenous Leukemia Trial in Worldwide (Dasatinib)

          Active, not recruiting
          • Chronic Myelogenous Leukemia
          • Amman, Jordan
          • +4 more
          Jan 17, 2022

          Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia Trial in Uijeongbu si (Asciminib single agent, Asciminib, Imatinib)

          Recruiting
          • Chronic Myelogenous Leukemia
          • Leukemia, Myelogenous, Chronic, BCR-ABL Positive
          • Asciminib single agent
          • +5 more
          • Ann Arbor, Michigan
          • +49 more
          Jan 26, 2023

          Leukemia Trial in Worldwide (Dasatinib)

          Completed
          Has Results
          • Leukemia
          • Vienna, Austria
          • +12 more
          Feb 24, 2021

          Expression Pattern of HNRNPH1 and HNRNPK Genes in MPNs

          Not yet recruiting
          • Myeloproliferative Neoplasms (MPNs)
          • Reverse transcription-quantitative polymerase chain reaction (RT-qPCR)
          • (no location specified)
          Mar 24, 2023

          Generic Imatinib in Chronic Myeloid Leukemia Patients in Egypt

          Completed
          • Philadelphia Chromosome-positive Chronic Myeloid Leukemia in Chronic Phase
          • Cairo, Egypt
            National Cancer Institute (NCI)
          Feb 22, 2021

          Chronic Phase Chronic Myeloid Leukemia Trial in Worldwide (Dasatinib)

          Completed
          Has Results
          • Chronic Phase Chronic Myeloid Leukemia
          • Duarte, California
          • +27 more
          Dec 7, 2021

          Concomitant Medications at CML Diagnosis

          Completed
          • Chronic Myeloid Leukemia
          • the prevalence of comorbid conditions
          • (no location specified)
          Sep 16, 2023

          Chronic Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in China (Ponatinib)

          Recruiting
          • Chronic Myeloid Leukemia
          • Acute Lymphoblastic Leukemia
          • Hefei, Anhui, China
          • +13 more
          Aug 11, 2020

          Hypertension Trial in San Francisco (BP Activate Letter, Control Letter)

          Active, not recruiting
          • Hypertension
          • BP Activate Letter
          • Control Letter
          • San Francisco, California
            University of California, San Francisco
          Nov 21, 2023

          Chronic Phase Chronic Myeloid Leukemia, Accelerated Phase Chronic Myeloid Leukemia, Blastic Phase Chronic Myeloid Leukemia Trial

          Completed
          • Chronic Phase Chronic Myeloid Leukemia
          • +4 more
          • Toronto, Ontario, Canada
            Princess Margaret Hospital / University Health Network
          Oct 29, 2020